| The effect of SGLT2 inhibitors on the endothelium and the microcirculation: From bench to bedside and beyond K Dimitriadis, E Adamopoulou, N Pyrpyris, A Sakalidis, I Leontsinis, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (8), 741-757, 2023 | 19 | 2023 |
| The common pathobiology between coronary artery disease and calcific aortic stenosis: Evidence and clinical implications T Abdul-Rahman, I Lizano-Jubert, N Garg, S Talukder, PP Lopez, ... Progress in Cardiovascular Diseases 79, 89-99, 2023 | 16 | 2023 |
| Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials S Agarwal, CW Beard, J Khosla, S Clifton, MF Anwaar, A Ghani, K Farhat, ... Europace 25 (7), euad169, 2023 | 13 | 2023 |
| LOX-1 receptor: A diagnostic tool and therapeutic target in atherogenesis N Pyrpyris, K Dimitriadis, E Beneki, P Iliakis, S Soulaidopoulos, P Tsioufis, ... Current Problems in Cardiology 49 (1), 102117, 2024 | 8 | 2024 |
| Unravelling the effect of renal denervation on glucose homeostasis: more questions than answers? E Koutra, K Dimitriadis, N Pyrpyris, P Iliakis, C Fragkoulis, E Beneki, ... Acta Diabetologica 61 (3), 267-280, 2024 | 7 | 2024 |
| A narrative review on exercise and cardiovascular events:“Primum non nocere” K Dimitriadis, E Bletsa, E Lazarou, I Leontsinis, P Stampouloglou, E Dri, ... Heart and Mind 6 (3), 127-138, 2022 | 7 | 2022 |
| The potential future role of extensive lipid lowering in ACS patients with the use of PCSK9 inhibitors: early bird catches the worm K Dimitriadis, N Pyrpyris, K Tsioufis European Heart Journal-Cardiovascular Pharmacotherapy 10 (2), 85-86, 2024 | 6 | 2024 |
| Coronary sinus narrowing therapy: A “Reducer” for angina and beyond K Dimitriadis, P Iliakis, N Pyrpyris, E Beneki, P Tsioufis, K Aznaouridis, ... Cardiovascular Revascularization Medicine 57, 96-105, 2023 | 5 | 2023 |
| Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures? K Dimitriadis, N Pyrpyris, K Aznaouridis, P Iliakis, A Valatsou, P Tsioufis, ... Life 13 (6), 1417, 2023 | 5 | 2023 |
| Management of dyslipidemia in coronary artery disease: The present and the future K Dimitriadis, P Theofilis, P Iliakis, N Pyrpyris, E Dri, A Sakalidis, ... Coronary Artery Disease 35 (6), 516-524, 2024 | 4 | 2024 |
| Computed tomography angiography identified high-risk coronary plaques: from diagnosis to prognosis and future management K Dimitriadis, N Pyrpyris, P Theofilis, E Mantzouranis, E Beneki, ... Diagnostics 14 (15), 1671, 2024 | 4 | 2024 |
| RNA in cardiovascular disease: A new frontier of personalized medicine T Abdul-Rahman, I Lizano-Jubert, ZSB Bliss, N Garg, E Meale, P Roy, ... Progress in Cardiovascular Diseases 85, 93-102, 2024 | 4 | 2024 |
| Atrial functional mitral regurgitation: From diagnosis to current interventional therapies P Iliakis, K Dimitriadis, N Pyrpyris, E Beneki, P Theofilis, P Tsioufis, ... Journal of Clinical Medicine 13 (17), 5035, 2024 | 3 | 2024 |
| Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand? K Dimitriadis, N Pyrpyris, P Iliakis, P Kanatas, P Theofilis, A Sakalidis, ... Journal of Cardiology, 2024 | 3 | 2024 |
| Intravascular imaging in ultra-low or zero-contrast percutaneous coronary interventions: the time is now? K Dimitriadis, N Pyrpyris, A Papanikolaou, E Beneki, P Tsioufis, ... Journal of Clinical Medicine 12 (23), 7499, 2023 | 3 | 2023 |
| Increased rhinovirus/enterovirus infections including Ev-D68 in the United States, a challenge for healthcare providers amidst influenza virus infection and the COVID-19 pandemic T Abdul-Rahman, A Nazir, B Khater, N Pyrpyris, AA Wireko, DG Miteu, ... Postgraduate Medical Journal 99 (1171), 372-374, 2023 | 3 | 2023 |
| Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus … K Dimitriadis, A Vakka, N Pyrpyris, A Apostolos, E Beneki, E Stathopoulou, ... American Journal of Cardiovascular Drugs 25 (1), 57-69, 2025 | 2 | 2025 |
| ANOCA updated: From pathophysiology to modern clinical practice K Dimitriadis, N Pyrpyris, A Sakalidis, E Dri, P Iliakis, P Tsioufis, F Tatakis, ... Cardiovascular Revascularization Medicine, 2024 | 2 | 2024 |
| Proprotein convertase subtilisin/kexin type 9 inhibitors in patients following acute coronary syndromes: from lipid lowering and plaque stabilization to improved outcomes K Dimitriadis, N Pyrpyris, P Iliakis, E Beneki, E Adamopoulou, ... Journal of Clinical Medicine 13 (17), 5040, 2024 | 2 | 2024 |
| Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship G Nayak, K Dimitriadis, N Pyrpyris, M Manti, N Kamperidis, V Kamperidis, ... Life 14 (4), 527, 2024 | 2 | 2024 |
Konstantinos TsioufisNational and Kapodistrian University of Athens, Medical School, GreeceVerified email at med.uoa.gr
